HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of combined administration of cytembena and cyclophosphamide on the blood count and morphology of nucleoli in peripheral-blood lymphocytes in patients with malignant tumors.

Abstract
In patients with malignant tumors, changes in the blood count and morphological changes in the nucleoli in peripheral-blood lymphocytes were studied during treatment with Cytembena, Cyclophosphamide, or combinations of both drugs. After administration of Cyclophosphamide (400 mg i.v. daily for 10 days, then 100 mg orally daily), the counts of leukocytes, especially of neutrophils, sank (by 40% maximally), and the erythrocyte count and the haemoglobin content in blood sank moderately. In peripheral-blood lymphocytes, the proportion of ring-shaped nucleoli (stimulable to synthesis of RNA) reversibly sank, and the proportion of micronucleoli (nonstimulable) rose. After administration of Cytembena (400 mg i.v. daily for 10 days, then 200 mg i.m. at intervals of 2--4 days), neither the leukocyte counts nor the relative percentages of lymphocytic nucleoli signigicantly changed; the mean corpuscular haemoglobin content (MCH) transitorily increased (by 10 percent max.). In the group receiving combined cytostatics (Cytembena 400 mg i.v. daily for 10 days, then 200 mg i.m. at intervals of 2--4 days plus Cyclophosphamide 50 mg orally daily), the erythrocyte count and the haemoglobin content in blood sank moderately. In the population of peripheral-blood lymphocytes in this group, there sank the absolute counts of lymphocytes with ring-shaped nucleoli (by 44% max.) and those with micronucleoli (by 33% max.).
AuthorsE Matĕjková
JournalNeoplasma (Neoplasma) Vol. 22 Issue 1 Pg. 45-54 ( 1975) ISSN: 0028-2685 [Print] Slovakia
PMID1173938 (Publication Type: Journal Article)
Chemical References
  • Acrylates
  • Antineoplastic Agents
  • Cyclophosphamide
Topics
  • Acrylates (administration & dosage, pharmacology)
  • Administration, Oral
  • Antineoplastic Agents (therapeutic use)
  • Blood Cell Count
  • Cell Nucleolus (drug effects)
  • Cyclophosphamide (administration & dosage, pharmacology, therapeutic use)
  • Drug Therapy, Combination
  • Erythrocyte Count
  • Humans
  • Injections, Intravenous
  • Leukocyte Count
  • Lymphocytes (drug effects)
  • Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: